Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Ardelyx, Inc. (ARDX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
0.9700+0.0410 (+4.41%)
At close: 04:00PM EDT
0.9800 +0.01 (+1.03%)
After hours: 05:18PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Intermediate-term KST

Intermediate-term KST

Previous Close0.9290
Open0.9196
Bid0.9655 x 1200
Ask0.9800 x 1200
Day's Range0.9152 - 0.9700
52 Week Range0.4900 - 1.9200
Volume3,958,517
Avg. Volume2,361,448
Market Cap149.997M
Beta (5Y Monthly)1.83
PE Ratio (TTM)N/A
EPS (TTM)-1.3610
Earnings DateNov 10, 2022 - Nov 14, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.29
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for ARDX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Ardelyx, Inc.
    Daily – Vickers Top Buyers & Sellers for 04/25/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    4 months agoArgus Research
View more
  • Zacks

    Ardelyx (ARDX) Reports Q2 Loss, Tops Revenue Estimates

    Ardelyx (ARDX) delivered earnings and revenue surprises of 0% and 307.42%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

  • PR Newswire

    Ardelyx Reports Second Quarter 2022 Financial Results and Recent Business Highlights

    Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs, today reported business updates and financial results for the second quarter ended June 30, 2022.

  • PR Newswire

    Ardelyx to Present at the 2022 Wedbush PacGrow Healthcare Conference

    Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs, today announced that Mike Raab, president and chief executive officer of Ardelyx, will participate in a virtual fireside chat at the 2022 Wedbush PacGrow Healthcare Conference. The fireside chat will take place on Tuesday, August 9, 2022, at 4:40 p.m. ET.

Advertisement
Advertisement